arrow
M

Meijuan Huang

Nanchang University
H指数:32
被引数:4,804

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Osimertinib after definitive chemoradiotherapy in patients with unresectable stage III EGFR-mutated NSCLC: LAURA China cohort

奥希替尼在不可切除的III期EGFR突变非小细胞肺癌患者中接受根治性放化疗后的应用:LAURA中国队列

2026-02-230
OAAI
Improving CAR-T cell function through a targeted cytokine delivery system utilizing car target-modified extracellular vesicles

通过靶向细胞因子递送系统,利用经CAR靶点修饰的细胞外囊泡来改善CAR-T细胞功能

2025-09-150
OAAI
Low-dose radiotherapy concurrent with atezolizumab and chemotherapy as first-line treatment for extensive-stage small-cell lung cancer: 3-year follow-up of a multicenter, single-arm, phase 2 trial (MATCH)

低剂量放射治疗与阿替利珠单抗和化疗联合作为广泛期小细胞肺癌的一线治疗方案:一项多中心、单臂、II期试验(MATCH)的3年随访研究

2025-07-010
OA
Superiority in the Longer Duration of Response and Better Central Nervous System Penetration of CAR-T Cell Therapy over Blinatumomab Infusion for Relapsed/ Refractory B-Cell Acute Lymphoblastic Leukemia: A Retrospective Single-Center Analysis

CAR-T细胞疗法在缓解持续时间更长和更优的中枢神经系统渗透性方面优于Blinatumomab输注治疗复发/难治性B细胞急性淋巴细胞白血病:一项回顾性单中心分析

BLOOD
IF23.1
2024-11-050
PRE